Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SERPINC1 | P01008 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13381167 | 0.86 | SERPINC1 (0.31) | SERPINC1 | |
| SCHEMBL13381154 | 0.85 | — | — | |
| SCHEMBL13381109 | 0.82 | SERPINC1 (0.33) | SERPINC1 | |
| SCHEMBL13381107 | 0.79 | SERPINC1 (0.30) | SERPINC1 | |
| SCHEMBL13381151 | 0.76 | SERPINC1 (0.30) | SERPINC1 | |
| SCHEMBL13381028 | 0.74 | SERPINC1 (0.30) | SERPINC1 | |
| SCHEMBL14227801 | 0.68 | SERPINC1 (0.37) | SERPINC1 | |
| SCHEMBL14227804 | 0.65 | SERPINC1 (0.40) | SERPINC1 | |
| SCHEMBL13039108 | 0.65 | SERPINC1 (0.54) | SERPINC1 | |
| SCHEMBL14221772 | 0.65 | GJB2 (0.38) | SERPINC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100081708-A1 | ANTICOAGULANT COMPOUNDS | ENDOTIS PHARMA (FR) | 2010-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100081708-A1 | ANTICOAGULANT COMPOUNDS | SERPINC1, F2, FUT5 | SERPINC1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.